Messoud Ashina

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 22

Top Topics

Systematic Review

Inferior Vena Cava

Middle Cerebral Artery

Top Venues

Nature reviews. Neurology

European journal of neurology

Pain management

This page only lists publications with an associated author ORCID identifier.

Publications

Todd J Schwedt, Amynah Amir Ali Pradhan, Michael L Oshinsky, Mitchell F Brin, Howard Rosen, Nim Lalvani, Andrew C Charles, Messoud Ashina, Thien Phu Do, Rami Burstein, Amy A Gelfand, David W Dodick, Patricia Pozo-Rosich, Richard B Lipton, Jessica Ailani, Christina L Szperka, Larry Charleston, Kathleen B Digre, Andrew F Russo, Dawn C Buse, Scott W Powers, Cristina Tassorelli, Peter J Goadsby, null null
The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group. Headache (2024)
Todd J Schwedt, Amynah Amir Ali Pradhan, Michael L Oshinsky, Mitchell F Brin, Howard Rosen, Nim Lalvani, Andrew C Charles, Messoud Ashina, Thien Phu Do, Rami Burstein, Amy A Gelfand, David W Dodick, Patricia Pozo-Rosich, Richard B Lipton, Jessica Ailani, Christina L Szperka, Larry Charleston, Kathleen B Digre, Andrew F Russo, Dawn C Buse, Scott W Powers, Cristina Tassorelli, Peter J Goadsby, null null
The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group. Headache 64 (8) (2024)
Håkan Ashina, Rune H Christensen, Debbie L Hay, Amynah A Pradhan, Jan Hoffmann, Dora Reglodi, Andrew F Russo, Messoud Ashina
Pituitary adenylate cyclase-activating polypeptide signalling as a therapeutic target in migraine. Nature reviews. Neurology (2024)
Todd J Schwedt, Amynah Amir Ali Pradhan, Michael L Oshinsky, Mitchell F Brin, Howard Rosen, Nim Lalvani, Andrew C Charles, Messoud Ashina, Thien Phu Do, Rami Burstein, Amy A Gelfand, David W Dodick, Patricia Pozo-Rosich, Richard B Lipton, Jessica Ailani, Christina L Szperka, Larry Charleston, Kathleen B Digre, Andrew F Russo, Dawn C Buse, Scott W Powers, Cristina Tassorelli, Peter J Goadsby, null null
The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group. Headache 64 (8) (2024)
Lionesa Bahtiri, Andreas Vinther Thomsen, Messoud Ashina, Anders Hougaard
Migraine aura-like episodes following sclerotherapy for varicose veins of the lower extremities-A systematic review. Headache 63 (1) (2023)
Messoud Ashina, Dimos D Mitsikostas, Verena Ramirez Campos, Steve Barash, Xiaoping Ning, Hans-Christoph Diener
Numbers needed to treat or harm and likelihood of being helped versus harmed for fremanezumab in patients who had prior inadequate response to two to four classes of migraine preventive medications: A post hoc analysis. Headache (2023)
Messoud Ashina, Stewart J Tepper, Uwe Reuter, Andrew M Blumenfeld, Susan Hutchinson, Jing Xia, Rosa Miceli, Lawrence Severt, Michelle Finnegan, Joel M Trugman
Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial. Headache 63 (1) (2023)
Lionesa Bahtiri, Andreas Vinther Thomsen, Messoud Ashina, Anders Hougaard
Migraine aura-like episodes following sclerotherapy for varicose veins of the lower extremities-A systematic review. Headache 63 (1) (2023)
Lionesa Bahtiri, Andreas Vinther Thomsen, Messoud Ashina, Anders Hougaard
Migraine aura-like episodes following sclerotherapy for varicose veins of the lower extremities-A systematic review. Headache (2023)
Messoud Ashina, Richard B Lipton, Jessica Ailani, Jan Versijpt, Simona Sacco, Dimos D Mitsikostas, Cecilie Laurberg Christoffersen, Bjørn Sperling, Anders Ettrup
Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial. European journal of neurology (2023)
Messoud Ashina, Stewart J Tepper, Uwe Reuter, Andrew M Blumenfeld, Susan Hutchinson, Jing Xia, Rosa Miceli, Lawrence Severt, Michelle Finnegan, Joel M Trugman
Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial. Headache (2023)
Lionesa Bahtiri, Andreas Vinther Thomsen, Messoud Ashina, Anders Hougaard
Migraine aura-like episodes following sclerotherapy for varicose veins of the lower extremities-A systematic review. Headache 63 (1) (2023)
Messoud Ashina, Stewart J Tepper, Uwe Reuter, Andrew M Blumenfeld, Susan Hutchinson, Jing Xia, Rosa Miceli, Lawrence Severt, Michelle Finnegan, Joel M Trugman
Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial. Headache 63 (1) (2023)
Stewart J Tepper, Richard B Lipton, Stephen D Silberstein, David Kudrow, Messoud Ashina, Uwe Reuter, David W Dodick, Andrea Wang, Sunfa Cheng, Jan Klatt, Daniel D Mikol
Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis. Headache (2023)
Messoud Ashina, Stewart J Tepper, Uwe Reuter, Andrew M Blumenfeld, Susan Hutchinson, Jing Xia, Rosa Miceli, Lawrence Severt, Michelle Finnegan, Joel M Trugman
Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial. Headache 63 (1) (2023)
Basit Ali Chaudhry, Thien Phu Do, Håkan Ashina, Messoud Ashina, Faisal Mohammad Amin
Cluster headache - The worst possible pain on YouTube. Headache 62 (9) (2022)
Messoud Ashina, Stewart J Tepper, Jan Lewis Brandes, Uwe Reuter, Guy P Boudreau, Mark Weatherall, Andreas R Gantenbein, David Doležil, Jan Klatt, Andrea Wang, Ananda Krishna Karanam, Sunfa Cheng, Daniel D Mikol
Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis. Headache 62 (5) (2022)
Andreas Vinther Thomsen, Morten Togo Sørensen, Messoud Ashina, Anders Hougaard
Symptomatic migraine: A systematic review to establish a clinically important diagnostic entity. Headache 61 (8) (2021)
Messoud Ashina, Faisal Mohammad Amin, Pinar Kokturk, Joshua M Cohen, Martijn Konings, Cristina Tassorelli, Leonidas Lyras, Dimos-Dimitrios Mitsikostas
PEARL study protocol: a real-world study of fremanezumab effectiveness in patients with chronic or episodic migraine. Pain management 11 (6) (2021)
Messoud Ashina, Joshua M Cohen, Sanjay K Gandhi, Evelyn Du
Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine. Headache 61 (6) (2021)
Agneta H Snoer, Anne Luise H Vollesen, Rasmus Paulin Beske, Song Guo, Jan Hoffmann, Niklas R Jørgensen, Torben Martinussen, Messoud Ashina, Rigmor H Jensen
S100B and NSE in Cluster Headache - Evidence for Glial Cell Activation? Headache 60 (8) (2020)
Nisar A Shayestagul, Casper Emil Christensen, Faisal Mohammad Amin, Sait Ashina, Messoud Ashina
Measurement of Blood Flow Velocity in the Middle Cerebral Artery During Spontaneous Migraine Attacks: A Systematic Review. Headache 57 (6) (2017)